These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 16903981

  • 1. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
    Gingues S, Gill MJ.
    HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
    [Abstract] [Full Text] [Related]

  • 2. [Epidemiology of HIV-associated malignancies].
    Launay O, Guillevin L.
    Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
    [Abstract] [Full Text] [Related]

  • 3. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S, Swiss HIV Cohort.
    J Natl Cancer Inst; 2005 Mar 16; 97(6):425-32. PubMed ID: 15770006
    [Abstract] [Full Text] [Related]

  • 4. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.
    Chaturvedi AK, Mbulaiteye SM, Engels EA.
    Ann Epidemiol; 2008 Mar 16; 18(3):230-4. PubMed ID: 18083545
    [Abstract] [Full Text] [Related]

  • 5. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
    Cornejo-Juárez P, Volkow-Fernández P, Avilés-Salas A, Calderón-Flores E.
    Rev Invest Clin; 2008 Mar 16; 60(5):375-81. PubMed ID: 19227434
    [Abstract] [Full Text] [Related]

  • 6. The epidemiology of acquired immunodeficiency syndrome malignancies.
    Goedert JJ.
    Semin Oncol; 2000 Aug 16; 27(4):390-401. PubMed ID: 10950365
    [Abstract] [Full Text] [Related]

  • 7. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ, Gazzard BG, Easterbrook PJ.
    J Infect; 2001 Feb 16; 42(2):134-9. PubMed ID: 11531320
    [Abstract] [Full Text] [Related]

  • 8. [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma].
    Gabarre J, Bossi P.
    Bull Cancer; 2003 May 16; 90(5):419-25. PubMed ID: 12850765
    [Abstract] [Full Text] [Related]

  • 9. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
    Barbaro G, Barbarini G.
    Oncol Rep; 2007 May 16; 17(5):1121-6. PubMed ID: 17390054
    [Abstract] [Full Text] [Related]

  • 10. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C, Lesens O, Villemagne B, Darcha C, Tournilhac O, Henquell C, Cormerais L, Gourdon F, Peigue-Lafeuille H, Travade P, Beytout J, Laurichesse H.
    Med Mal Infect; 2006 Mar 16; 36(3):157-62. PubMed ID: 16503104
    [Abstract] [Full Text] [Related]

  • 11. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
    Robotin MC, Law MG, Milliken S, Goldstein D, Garsia RJ, Dolan GM, Kaldor JM, Grulich AE.
    HIV Med; 2004 Sep 16; 5(5):377-84. PubMed ID: 15369514
    [Abstract] [Full Text] [Related]

  • 12. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE, Kaplan LD.
    Oncology (Williston Park); 2002 Apr 16; 16(4):441-51, 456, 459. PubMed ID: 12017534
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic approaches to AIDS-related malignancies.
    Berretta M, Cinelli R, Martellotta F, Spina M, Vaccher E, Tirelli U.
    Oncogene; 2003 Sep 29; 22(42):6646-59. PubMed ID: 14528290
    [Abstract] [Full Text] [Related]

  • 14. AIDS-associated malignancies.
    Akanmu AS.
    Afr J Med Med Sci; 2006 Dec 29; 35 Suppl():57-70. PubMed ID: 18050776
    [Abstract] [Full Text] [Related]

  • 15. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
    Tserenpuntsag B, Kołacińska A, Jabłonowska E.
    Przegl Epidemiol; 2007 Dec 29; 61(3):529-34. PubMed ID: 18069390
    [Abstract] [Full Text] [Related]

  • 16. Less cancer--or more--with HAART? Or, reflections on a late opus.
    Mascolini M.
    J Int Assoc Physicians AIDS Care; 1998 Jun 29; 4(6):12-22. PubMed ID: 11365531
    [Abstract] [Full Text] [Related]

  • 17. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE, Kaplan LD.
    Oncology (Williston Park); 2002 May 29; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
    [Abstract] [Full Text] [Related]

  • 18. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
    Diamond C, Taylor TH, Aboumrad T, Anton-Culver H.
    Cancer; 2006 Jan 01; 106(1):128-35. PubMed ID: 16329140
    [Abstract] [Full Text] [Related]

  • 19. Changing incidence of AIDS-related Kaposi sarcoma and non-Hodgkin lymphoma in Ontario, Canada.
    Bahl S, Theis B, Nishri D, Marrett LD.
    Cancer Causes Control; 2008 Dec 01; 19(10):1251-8. PubMed ID: 18618279
    [Abstract] [Full Text] [Related]

  • 20. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC, Pantanowitz L, Dezube BJ.
    Oncologist; 2005 Dec 01; 10(6):412-26. PubMed ID: 15967835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.